Logo Image
Joint Ventures: Unpacking the History and Modern Use of Steroids in Rheumatology

Joint Ventures: Unpacking the History and Modern Use of Steroids in Rheumatology

Featuring Rihards Buss, MD, Jack Arnold, MBBS, MRCP, PhD

Watch Now
Joint Ventures Recaps Influential EULAR Studies in SLE, RA, and More

Joint Ventures Recaps Influential EULAR Studies in SLE, RA, and More

Featuring Rihards Buss, MD, Jack Arnold, MBBS, MRCP, PhD

Watch Now
Joint Ventures: Lupus Health Inequalities, Growing Burden of ICI-Arthritis at EULAR 2026

Joint Ventures: Lupus Health Inequalities, Growing Burden of ICI-Arthritis at EULAR 2026

Featuring Rihards Buss, MD, Sarah Dyball, MBBS, PhD, Kate Harnden, MBChB

Watch Now
Joint Ventures: Aiming for Targeted First-Line Therapy in Early RA at EULAR 2026

Joint Ventures: Aiming for Targeted First-Line Therapy in Early RA at EULAR 2026

Featuring Jack Arnold, MBBS, MRCP, PhD, Laurence Duquenne, MD, PhD

Watch Now
Joint Ventures: CAR-T, Early Diagnosis Reshape Scleroderma at EULAR 2026

Joint Ventures: CAR-T, Early Diagnosis Reshape Scleroderma at EULAR 2026

Featuring Jack Arnold, MBBS, MRCP, PhD, Vishal Kakkar, MD

Watch Now
Joint Ventures: EULAR 2026 Congress Preview

Joint Ventures: EULAR 2026 Congress Preview

Featuring Rihards Buss, MD, Jack Arnold, MBBS, MRCP, PhD

Watch Now
Joint Ventures: The B-Cell Story, Part 2 — Ianalumab and the Next Chapter in Sjögren's and Lupus

Joint Ventures: The B-Cell Story, Part 2 — Ianalumab and the Next Chapter in Sjögren's and Lupus

Featuring Rihards Buss, MD, Jack Arnold, MBBS, MRCP, PhD, Lucy Carter, MBBS, PhD

Watch Now
Joint Ventures: The B-Cell Story, Part 1 — From Rituximab to the Next Frontier

Joint Ventures: The B-Cell Story, Part 1 — From Rituximab to the Next Frontier

Featuring Rihards Buss, MD, Jack Arnold, MBBS, MRCP, PhD

Watch Now

Trending Videos

Joint Ventures: Gout Management Gaps Persist Despite Effective Therapies, Guidelines
1

Joint Ventures: Gout Management Gaps Persist Despite Effective Therapies, Guidelines

News

TOGETHER-PsA:Tirzepatide + Ixekizumab Rapidly Improves PsA Disease Control With Obesity/Overweight
2

TOGETHER-PsA:Tirzepatide + Ixekizumab Rapidly Improves PsA Disease Control With Obesity/Overweight

Commentary

Clinical Pearls for Nutrition and Weight Loss in PsA
3

Clinical Pearls for Nutrition and Weight Loss in PsA

Opinion

Joint Ventures: EULAR 2026 Congress Preview
4

Joint Ventures: EULAR 2026 Congress Preview

Commentary

Slow But Steady: Real-World Data Supports Avacopan Use in GPA/MPA
5

Slow But Steady: Real-World Data Supports Avacopan Use in GPA/MPA

Commentary

The Path to Diagnosis of Psoriatic Arthritis
6

The Path to Diagnosis of Psoriatic Arthritis

Opinion

Joint Ventures Recaps Influential EULAR Studies in SLE, RA, and More
7

Joint Ventures Recaps Influential EULAR Studies in SLE, RA, and More

News

Why 3 Months of Romosozumab May Fall Short for Hip Bone Strength
8

Why 3 Months of Romosozumab May Fall Short for Hip Bone Strength

News

Emerging Research and Reduction in Medication Use with Combination PsA Care
9

Emerging Research and Reduction in Medication Use with Combination PsA Care

Opinion

Early Joint Clearance With Bimekizumab Leads to Durable Disease Control in PsA
10

Early Joint Clearance With Bimekizumab Leads to Durable Disease Control in PsA

Commentary

Shorts

Be Proactive in Gout Management
1:11
Be Proactive in Gout Management
3 hours ago
by
Jack Arnold, MBBS, MRCP, PhD
ALLEGORY: Expanding Obinutuzmab to SLE
2:05
ALLEGORY: Expanding Obinutuzmab to SLE
2 months ago
by
Maria Dall'Era, MD
Hidden Inequities in Lupus Care and Steroid Use
0:46
Hidden Inequities in Lupus Care and Steroid Use
3 months ago
by
Sarah Dyball, MBBS, PhD(+1 more)
Why Does ICI-Induced Inflammatory Arthritis Persist?
0:39
Why Does ICI-Induced Inflammatory Arthritis Persist?
4 months ago
by
Kate Harnden, MBChB
CAR T's Place in Lupus Treatment
1:01
CAR T's Place in Lupus Treatment
5 months ago
by
Rihards Buss, MD(+2 more)
A Vicious Cycle: Obesity and Autoimmune Disease
0:38
A Vicious Cycle: Obesity and Autoimmune Disease
6 months ago
by
Jack Arnold, MBBS, MRCP, PhD
GLP-1's Benefit for Osteoarthritis
0:44
GLP-1's Benefit for Osteoarthritis
7 months ago
by
Jack Arnold, MBBS, MRCP, PhD
Favorable Benefit-Risk Profile With Osteoporosis Prevention
0:53
Favorable Benefit-Risk Profile With Osteoporosis Prevention
8 months ago
by
Gina Woods, MD
Imaging Advances in Vasculitis
0:33
Imaging Advances in Vasculitis
8 months ago
by
Anisha B. Dua, MD, MPH
Shifting Attention to Difficult-to-Treat PsA and AxSpA
0:51
Shifting Attention to Difficult-to-Treat PsA and AxSpA
8 months ago
by
Eric M. Ruderman, MD

Expert Conversations

Peers & Perspectives
Insights
Cure Connections
Clinical Forum Insights
Peer Exchange

Shows & Podcasts

Medcast
Joint Ventures

News & Analysis

Special Report
Videos